Kays Medical

HepatitisB

Showing all 6 results

  • Engerix B PFS (Hepatitis B) – 20mcg/1ml (1) *POM*

    £44.07 + VAT
    Engerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects.It can be expected that hepatitis D will also be prevented by immunisation with Engerix B as hepatitis D...
  • Engerix B PFS (Hepatitis B) – 20mcg/1ml (10) *POM*

    £405.43 + VAT
    Engerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects.It can be expected that hepatitis D will also be prevented by immunisation with Engerix B as hepatitis D...
  • Placeholder

    Engerix B Vial (Hepatitis B) – 20mcg/1ml (1) *POM*

    £42.39 + VAT
    Engerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects. The 20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above.
  • Placeholder

    Engerix B Vial (Hepatitis B) – 20mcg/1ml (10) *POM*

    £405.43 + VAT
    Engerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects. The 20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above.
  • HB Vax Pro PFS – 10mcg/1ml *POM*

    £34.70 + VAT
    HBVAXPRO is indicated for active immunisation against hepatitis B virus infection caused by all known subtypes in individuals 16 years of age or more considered at risk of exposure to hepatitis B virus.The specific at risk categories to be immunised...
  • HB Vax Pro PFS – Paediatric – 5mcg/0.5ml *POM*

    £38.33 + VAT
    HBVAXPRO is indicated for active immunisation against hepatitis B virus infection caused by all known subtypes in individuals from birth through 15 years of age considered at risk of exposure to hepatitis B virus.The specific at risk categories to be...